40
42
Growth Score 40 in past quarter
-24 pts
Heat Score 42 in past quarter
7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
246163
MedPharm is a world-leading contract provider of topical and transdermal product design and development services.
Acquired by 

Tergus Pharma
Past Role: Merz Pharma, President and Chief Executive Officer- Stephanie Proesel: VP of Sales & Marketing

Tergus Pharma
About the Company
MedPharm is the world’s leading contract provider of topical and transdermal product design and formulation development services. MedPharm are experts at reducing risk and accelerating development times for generic and proprietary pharmaceutical customers through their unique, cost-effective, and industry-leading performance testing models.
Well-established as the global leaders in dermatology, nail, mucosal membrane, and transdermal product development, MedPharm can also offer innovative solutions for ophthalmic and airway preparations recognized for their scientific rigor by regulators and investors.
MedPharm has fully established Centres of Excellence in Durham, NC, USA and Guildford, Surrey, UK.
